Skip to main navigation

Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Shareholder Services

Back to CRISPR »

Presentations

Presentations

Jan 2021

CRISPR Tx Corporate Overview – January 2021 1.5 MB

Dec 2020

Phase 1/2 CTX001™ Investor Update Presentation 902.7 KB

Dec 2020

2020 ASH Meeting and Exposition Presentation 2.8 MB

Oct 2020

Phase 1 CARBON Top-Line Data Presentation 1.2 MB

Jun 2020

2020 AACR II Virtual Meeting Poster: Functional and single-cell assessment of CRISPR-modified CAR-T cells from NSCLC patients and healthy donors 466.7 KB

Jun 2020

2020 AACR II Virtual Meeting Poster: Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro 522.4 KB

Jun 2020

2020 AACR II Virtual Meeting Poster: Allogeneic anti-PTK7 CAR-T cells for the treatment of solid tumors 628.8 KB

Jun 2020

2020 AACR II Virtual Meeting Poster: Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells 415.8 KB

Jun 2020

2020 European Hematology Association (EHA) Congress Presentation 1.4 MB

May 2020

2020 ASGCT Annual Meeting Poster: Dual Guide CRISPR/Cas9 Editing of the CCR5 Gene Provides Complete Protection Against HIV in Humanized Mouse Models 249.4 KB

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 23

Print Page
RSS Feeds
Email Alerts
Contact IR

Interested in joining our team? Careers at CRISPR

© 2021 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions